Blog / Archives
Biotech Bear Market Rally is Fading…
Biotech Bear Market Rally is Fading but Traders Are Favored Long Term Concerns on Drug Pricing Remain The biotech sector is still lagging other sectors in 2016 down 20.93% with the IBB compared to...
Biotech Stocks Get Traction But Still Lag Broader Market…Update-2…Rally Mode
Update-2... Broad Tradable Rally Continues 12:30 PM EST XBI leads IBB today up 4.2% vs 2.9%. XBI at $54 is now up 9.55% over 5 days and well off Feb. 11 bottom of $44. This is a broad rally today...
Can El Nino Finally Save the West Coast Winter? Yes!
Update-1... 3/4/16 20-40 inches this weekend: Mammoth Mountain Snowman Report ------- Breakdown of High Pressure Ridge Will Bring Storms Next Week Over the past two weeks El Nino has gotten no...
Crude Stabilizes then Biotech Turns Green: Stay Tuned But Cautious
Biotech Stocks Off Lows Tracking Crude and Energy sector... 11.45 a EST Can healthcare stocks uncouple from energy and macro? Individual biotech stocks look very tradable with green catching up...
Biotech Stocks Lag Today’s Rally: S&P 500 Erases February Losses But Still Down 4.4% YTD…Update-1
2/23 After Close---Energy Rout Burns Biotech Stocks and NASDAQ The red screen dominated except few winners like ZIOPHARM Oncology (ZIOP) up 13.95% on a publication regarding gene editing. Another...
Large Cap Biopharma Winners and Losers 2015-16: Which Stocks Can Beat the ETFs?… Part 2
Rayno Large Cap Biopharmaceuticals...Part 2...A Stock pickers Market Time to Rebuild Your Portfolio: ABBV, BMY, GILD Below we have summarized selective metrics for large cap biopharmaceutical...
Biotech Bear Market Update: Barely Bouncing Off the Bottom
Have we reached a tradeable bottom in the biotech bear market? Today's tape showed good volume but gains faded late in session. NASDAQ up 0.35% XLV up 0.88%-healthcare is the leading sector...
Three Biotech Stocks To Buy Now: ABBV,BLUE,GILD…Update-2
2/5/16 ...11:20 AM Biotechs Can't Hold Gains ...Drop Back Near 52 Week Lows Hit Wednesday IBB $261 XBI $48 Update-2 At Close 2/4/16...Nice Rally But Off Earlier Highs-Very Stock Specific A nice...
Large Cap Biopharmaceuticals Winners and Losers 2015-16: Which Stocks Can Outperform the ETFs in 2016?… Part 1
Where is the Growth Potential in Large Cap Biopharmaceutical Companies? Caution: Risk Aversion Remains High Investing in biotech stocks ain't getting easier. The sector is underperforming the market...
Rayno Dx and Tools: Abbott (ABT) Buys Alere (ALR) For $5.8B Expanding Point-of-Care Diagnostics Platforms
Abbott Laboratories Acquires Alere (ALR) -Stock Soars 45% At Market Opening Alere Product Line Offers Synergies and Boosts Global Diagnostics Presence 2015 Revenues of Alere Are Estimated in $2.5B...